Suscribirse

Association of triglyceride-glucose index with all-cause and cause-specific mortality in different subgroups: A prospective study in the UK Biobank - 06/12/25

Doi : 10.1016/j.ando.2025.102454 
Ling-Huan Bu a, b, 1, Li-Ning He c, 1, Xiao Liu a, b, Jia-Xin Wu a, b, Yi-Qun Yang a, b, Yan-Hua Yang c, Fei-Yan Deng a, b, Shu-Feng Lei a, b, c,
a Center for Genetic Epidemiology and Genomics, School of Public Health, Suzhou Medical College of Soochow University, Jiangsu, China 
b  Jiangsu Key Laboratory of Preventive and Translational Medicine for Major Chronic Non-communicable Diseases, MOE Key Laboratory of Geriatric Diseases and c Immunology, Soochow University, Jiangsu, China  
c The Affiliated Changzhou Hospital of Geriatric Disease, School of Public Health, Suzhou Medical College of Soochow University, Jiangsu, China 

Corresponding author at: Center for Genetic Epidemiology and Genomics, School of Public Health, Suzhou Medical College of Soochow University, Suzhou, Jiangsu 215123, China. Center for Genetic Epidemiology and Genomics, School of Public Health, Suzhou Medical College of Soochow University Suzhou Jiangsu 215123 China

Abstract

Background

The triglyceride–glucose (TyG) index has been proposed as a reliable surrogate marker of insulin resistance. Correlation with mortality has produced inconsistent results in studies involving different populations. The present study used data from a large prospective cohort study to evaluate the association of TyG index with all-cause and cause-specific mortality and potential influencing factors, particularly exploring associations and correlations with mortality of thresholds in different subgroups of the population.

Methods

A total of 240,258 participants from the UK Biobank were included for analysis. Kaplan–Meier curves and Cox proportional hazards models were applied to estimate the associations between the TyG index and all-cause and cause-specific mortality. Subgroup analyses examined the closeness of associations in different populations. Dose-response relationships between TyG index and different risks of death in different subgroups were analyzed using restricted cubic spline (RCS), and risk thresholds were identified. Interaction tests and subgroup analyses explored potential influences.

Results

The TyG index exhibited a significant positive association with all-cause, cardiovascular, oncologic, diabetic and kidney-related mortality. A J-shaped relationship was observed between TyG index and mortality in diabetes and kidney disease. The relationship was stronger in females, subjects aged < 65 years, with abdominal obesity, smokers, with alcohol abuse, HbA1c 7%, prediabetes/diabetes, no hypertension and no hyperlipidemia. In addition, there were different patterns of dose-response relationships between TyG index and mortality in different subgroups of the population. We identified thresholds for each association.

Conclusion

Higher TyG index was associated with higher all-cause, oncologic, cardiovascular, diabetic and kidney-related mortality. There were differences in TyG threshold for different causes of death in different subgroups. The study identified thresholds for each association, providing more precise evidence for risk stratification and clinical decision-making.

El texto completo de este artículo está disponible en PDF.

Keywords : Triglyceride-glucose index, Insulin resistance, All-cause mortality, Cause-specific mortality


Esquema


© 2025  Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 86 - N° 5

Artículo 102454- septembre 2025 Regresar al número
Artículo precedente Artículo precedente
  • Cost-utility analysis of second line acromegaly treatment in France
  • Gérald Raverot, Philippe Chanson, Brigitte Delemer, Delphine Drui, Claire Briet, Amandine Ferriere, Maud Beillat, Wassila Aissani, Elise Cabout, Haifa Ben Romdhane, Thierry Brue
| Artículo siguiente Artículo siguiente
  • Analysis of genetic predisposition to familial non-medullary thyroid cancer by whole genome sequencing
  • Christine Do Cao, Rachel Desailloud, Hélène Topolinski, Michel Crépin, Cathy Flament, Emmanuelle Leteurtre, Catherine Cardot-Bauters, Fredéric Frénois, Émilie Ait-Yahya, Fabrice Bonte, Julie Leclerc, Pascal Pigny

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.